Using Simulation to Improve Drug-Delivery Effectiveness - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Using Simulation to Improve Drug-Delivery Effectiveness
Pharmaceutical companies are responding to the high cost of introducing new drugs to market in different ways.

Pharmaceutical Technology
pp. 38-42


1. C.P. Adams and V.V. Brantner, Health Aff. 25 (2) 420–428 (2006).

2. H. Schubert, Chem. Ing. Tech. 51 (4) 266–277 (1979).

3. J. Visser, Powder Tech., 58 (1) P1–1- (1989).

4. H. Krupp, Adv. Colloid Int. Sci. 1 (2) 111–239 (1967).

5. D.H. Geroski and H.F. Edelhauser, IOVS 41 (5) 961–964 (2000).

6. P.J. Missel, M. Horner, and R. Muralikrishnan, Pharm Res., 27 (8) 1530–1546 (2010).

7. R. K. Balachandran and V.H. Barocas, Pharm Res. 25 (11) 2685–2696 (2008).

8. S. Kandavilli, V. Nair, and R. Panchagnula, Pharm. Technol. 26 (4) 62–80 (2002).

9. J.E. Rim, P.M. Pinsky, and W.W. van Osdol, Annals Biomed. Eng. 33 (10) 1422–1438 (2005).

10. M. Horner, Desktop Eng., April 1, 2011,


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here